Robert Z. Orlowski, MD, from MD Anderson Cancer Center discusses Phase III Trial for multiple myeloma and Busulfan + Melphalan VS Melphalan alone at the 2017 American Society of Hematology.
Phase III Trial for Multiple Myeloma – Busulfan + Melphalan Vs Melphalan Alone
